PATH
Menu

This qualitative study investigated the perceptions and policy implications of home and self-injection of Sayana® Press in Ethiopia’s Oromia region. Sayana® Press is the subcutaneous formulation of the three-month injectable depot medroxyprogesterone acetate (DMPA) in the Uniject™ injection system. This study did not include actual product use in humans.

Corporate author(s): PATH

Publication date: May 2013

Available materials

English

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Africa

See also: Reproductive healthFamily planning

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA